Coronavirus vaccine: Pakistan approves AstraZeneca vaccine for emergency use

AstraZeneca vaccine

The jab would be the third available for the 27-nation European Union after the Pfizer-BioNTech and Moderna drugs, as the bloc struggles to speed up the rollout.

Australian scientists have asked the government to review its coronavirus vaccination strategy, the Financial Times reported. They stated that the vaccines are not enough to generate herd immunity against the virus, as per media reports. However, the Chinese vaccine is still to be approved by the Drug Regulatory Authority of Pakistan (DRAP).

The head of the Oxford Vaccine Group, Andrew Pollard, told the ABC the impact of vaccines was not determined by efficacy during clinical trials, but "when they're in people's arms". Hence, it can wait for a month and source the best vaccine in the meantime.

"We are in the advance stages of a vaccine drive".

The NCOC chief said the AstraZeneca-Oxford vaccine has already been okayed by DRAP and China's Sinopharm was also approved in principle by a technical committee.

"It's which one is available to give the maximum roll-out of vaccine to save lives and to protect lives this year", he said.

Crucially, the AstraZeneca vaccine is just one of the four the Australian government has entered into agreements to secure.

Pakistan is in the process of speaking to a number of vaccine makers, but this is the first local approval.

Astrazeneca's COVID-19 vaccine has been granted approval for emergency use in Pakistan, the country's health minister said on Saturday, the first vaccine against the disease to be given the green light in the South Asian country.

In addition to these drugs, the Australian authorities expected to receive their own vaccine against coronavirus, which was developed by the University of Queensland and the biotechnology company CSL. Some of the participants, who took part in the trials run by the University of Queensland and CSL, returned false positives for HIV.